Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients

Biological Psychiatry

Volumn 41, Issue 2, 1997, Pages 162-171

  Mann, J John ^a   Malone, Kevin M ^a  

^a Columbia University ^*  (United States)

Author keywords

5 hydroxyindoleacetic acid; cerebrospinal fluid; depression; homovanillic acid 3 methoxy 4 hydroxyphenylglycol; suicide attempt

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; SEROTONIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DEPRESSION; FEMALE; HUMAN; LETHALITY; MALE; PRIORITY JOURNAL; SUICIDE ATTEMPT;

ADULT; DEPRESSIVE DISORDER; FEMALE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; MIDDLE AGED; PERSONALITY INVENTORY; SEROTONIN; SUICIDE, ATTEMPTED;

EID: 0031040710     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00217-X     Document Type: Article

References (61)

1. Ågren H, Niklasson F (1986): Suicidal potential in depression: Focus on CSF monoamine and purine metabolites. Psychopharmacol Bull 22:656-660.
2. Arango V, Mann JJ (1992): Relevance of serotonergic postmortem studies to suicidal behavior. Int Rev Psychiatry 4:131-140.
3. 2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47: 1038-1047.
4. Åsberg M (1989): Neurotransmitter monoamine metabolites in the cerebrospinal fluid as risk factors for suicidal behavior. In Davidson L, Linnoila M (eds), Report of the Secretary's Task Force On Youth Suicide. Washington, DC: U.S. Health & Human Services, pp 2-193-2-212.
5. Åsberg M, Träskman L (1981): Studies of CSF 5-HIAA in depression and suicidal behavior. Adv Exp Med Biol 133:739-752.
6. Åsberg M, Träskman L, Thorén P (1976): 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33:1193-1197.
7. Banki CM, Arató M (1983): Amine metabolites and neuroendocrine responses related to depression and suicide. J Affect Disord 5:223-232.
8. Beck AT, Steer RA (1989): Clinical predictors of eventual suicide: A 5-to 10-year prospective study of suicide attempters. J Affect Disord 17:203-209.
9. Beck AT, Beck R, Kovacs M (1975): Classification of suicidal behaviors: I. Quantifying intent and medical lethality. Am J Psychiatry 132:285-287.
10. Beck AT, Kovacs M, Weissman A (1979): Assessment of suicidal intention: The scale for suicide ideation. J Consult Clin Psychol 47:343-352.
11. Beskow J, Gottfries CG, Roos BE, Winblad B (1976): Determination of monoamine and monoamine metabolites in the human brain: Post mortem studies in a group of suicides and in a control group. Acta Psychiatr Scand 53:7-20.
12. Bourne HR, Bunney WEJ, Colburn RW, Davis JM, Shaw DM, Coppen AJ (1968): Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. Lancet ii:805-808.
13. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979): Aggression in human correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1:131-139.
14. Brown GL, Ebert MH, Goyer PF, et al (1982): Aggression, suicide and serotonin: Relationships to CSF amine metabolites. Am J Psychiatry 139:741-746.
15. Cochran E, Robins E, Grote S (1976): Regional serotonin levels in brain: A comparison of depressive suicides and alcoholic suicides with controls. Biol Psychiatry 11:283-294.
16. Cooper SJ, Kelly CB, King DJ (1992): 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia. Lancet 340:940-941.
17. Edman G, Åsberg M, Levander S, Schalling D (1986): Skin conductance habituation and cerebrospinal fluid 5-hydroxyindoleacetic acid in suicidal patients. Arch Gen Psychiatry 43:586-592.
18. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
19. Higley JD, Thompson WW, Champoux M, et al (1993): Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in Rhesus monkeys (Macaca mulatta). Arch Gen Psychiatry 50:615-623.
20. Hildebrand J, Bourgeois F, Buyse M, Przedborski S, Goldman S (1990): Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid. Acta Neurol Scand 81:427-430.
21. Jones JS, Stanley B, Mann JJ, et al (1990): CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide. Am J Psychiatry 147:1225-1227.
22. Korpi ER, Kleinman J, Goodman SI, et al (1986): Serotonin and 5-hydroxyindoleacetic acid in brains of suicide victims. Comparison in chronic schizophrenic patients with suicide as cause of death. Arch Gen Psychiatry 43:594-600.
23. Lennard-Jones JE, Asher R (1959): Why do they do it? A study of pseudocide. Lancet i:l138-1140.
24. Lidberg L, Tuck JR, Åsberg M, Scalia Tomba GP, Bertilsson L (1985): Homicide, suicide and CSF 5-HIAA. Acta Psychiatr Scand 71:230-236.
25. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimond R, Goodwin FK (1983): Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci 33:2609-2614.
26. Lloyd KG, Parley IJ, Deck JHN, Hornykiewicz O (1974): Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients. Adv Biochem Psychopharmacol 11:387-397.
27. Lopez-Ibor JJ, Saiz-Ruiz R, Perez de los Cobos JC (1985): Biological correlations of suicide and aggressivity in major depressions (with melancholia): 5-Hydroxyindoleacetic acid and cortisol in cerebral spinal fluid, dexamethasone suppression test and therapeutic response to 5-hydroxytryptophan. Neuropsychobiology 14:67-74.
28. Loranger AW, Susman VL, Oldham JM, Russakoff LM (1987): The Personality Disorder Examination: a preliminary report. J Pers Disord 1:1-13.
29. Loranger AW, Lenzenweger MF, Gartner AF, et al (1991): Trait-state artifacts and the diagnosis of personality disorders. Arch Gen Psychiatry 48:720-728.
30. Malone KM, Corbitt EM, Li S-H, Mann JJ (1996): Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 168:324-329.
31. Mann JJ, Arango V (1992): Integration of neurobiology and psychopathology in a unified model of suicidal behavior. J Clin Psychopharmacol 12:2S-7S.
32. Mann JJ, Kapur S (1991): The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry 48:1027-1033.
33. Mann JJ, Arango V, Marzuk PM, Theccanat S, Reis DJ (1989): Evidence for the 5-HT hypothesis of suicide: A review of post-mortem studies. Br J Psychiatry 155(suppl 8):7-14.
34. Mann JJ, McBride PA, Brown RP, et al (1992): Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry 49:442-446.
35. Mann JJ, Goodwin FK, O'Brien CP, Robinson DS (1993): Suicidal behavior and psychotropic medication. Accepted as a consensus statement by the ACNP Council, March 2, 1992. Neuropsychopharmacology 8:177-183.
36. Mann JJ, Underwood MD, Arango V (1996): Postmortem studies of suicide victims. In Watson SJ (ed), Biology of Schizophrenia and Affective Disease, 1st ed. Washington, DC: American Psychiatric Press, pp 197-220.
37. Mann JJ, Malone KM, Sweeney JA, et al (in press): Attempted suicide characteristics and cerebrospinal fluid amine metabolites in depressed inpatients. Br J Psychiatry.
38. Mieczkowski TA, Sweeney JA, Haas GL, Mann JJ, Brown RP, Junker B (1993): Factor composition of the suicide intent scale. Suicide Life Threat Behav 23:37-45.
39. Moses SG, Robins E (1975): Regional distribution of norepinephrine and dopamine in brains of depressive suicides and alcoholic suicides. Psychopharmacol Comm 1:327-337.
40. Nordin C (1988): Relationships between clinical symptoms and monoamine metabolite concentrations in biochemically defined subgroups of depressed patients. Acta Psychiatr Scand 78:720-729.
41. Nordström P, Samuelsson M, Asberg M, et al (1994): CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 24:1-9.
42. Palaniappan V, Ramachandran V, Somasundaram O (1983): Suicidal ideation and biogenic amines in depression. Indian J Psychiatry 25:286-292.
43. Pare CMB, Yeung DPH, Price K, Stacey RS (1969): 5-Hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning. Lancet ii:133-135.
44. Paul SM, Rehavi M, Skolnick P, Goodwin FK (1984): High affinity binding of antidepressants to a biogenic amine transport site in human brain and platelet: studies in depression. In Post RM, Bellinger CJ (eds), Neurobiology of Mood Disorders. Baltimore: Williams and Wilkins, pp 846-853.
45. Roy A, Ågren H, Pickar D, et al (1986): Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: Relationship to suicidal behavior and dexamethasone nonsuppression. Am J Psychiatry 143:1539-1545.
46. Roy A, De Jong J, Linnoila M (1989): Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Arch Gen Psychiatry 46:609-612.
47. Roy-Byrne P, Post RM, Rubinow DR, Linnoila M, Savard R, Davis D (1983): CSF 5-HIAA and personal and family history of suicide in affectively ill patients: A negative study. Psychiatry Res 10:263-274.
48. Scheinin M, Chang W-H, Kirk KL, Linnoila M (1983): Simultaneous determination of 3-methoxy-4-hydroxphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection. Anal Biochem 131:246-253.
49. Secunda SK, Cross CK, Koslow S, et al (1986): Biochemistry and suicidal behavior in depressed patients. Biol Psychiatry 21:756-767.
50. Shaw DM, Camps FE, Eccleston EG (1967): 5-Hydroxytryptamine in the hind-brain of depressive suicides. Br J Psychiatry 113:1407-1411.
51. Spitzer RL, Williams JBW, Gibbon M, First MB (1989): Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID, 5/1/89 revision). New York: Biometrics Research Department, New York State Psychiatric Institute.
52. Spitzer RL, Williams JBW, Gibbon M, First MB (1992): The structured clinical interview for DSM-III-R (SCID): I. History, rationale, and description. Arch Gen Psychiatry 49:624-629.
53. Stanley M, Mann JJ (1983): Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet i:214-216.
54. Stanley M, Virgilio J, Gershon S (1982): Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216:1337-1339.
55. Stanley M, Träskman-Bendz L, Dorovini-Zis K (1985): Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 37:1279-1286.
56. Stengel E (1973): Suicide and Attempted Suicide. Harmondsworth, Middlesex: C. Nicholls & Company Ltd.
57. Träskman L, Åsberg M, Bertilsson L, Sjöstrand L (1981): Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38:631-636.
58. van Praag HM (1982): Depression, suicide and the metabolism of serotonin in the brain. J Affect Disord 4:275-290.
59. Vestergaard P, Sorensen T, Hoppe E, Rafaelsen OJ, Yates CM, Nicolaou N (1978): Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders. Acta Psychiatr Scand 58:88-96.
60. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M (1987): Cerebrospinal fluid monoamine metabolites levels in male arsonists. Arch Gen Psychiatry 44:241-247.
61. Westenberg HG, Verhoeven WM (1988): CSF monoamine metabolites in patients and controls: Support for a bimodal distribution in major affective disorders. Acta Psychiatr Scand 78:541-549.